Neurological-related proteomic profiling in plasma of children with metabolic healthy and unhealthy overweight/obesity
Metadatos
Mostrar el registro completo del ítemFecha
2024Referencia bibliográfica
Pediatric Obesity. 2024; e13155.
Resumen
Objective: Children with overweight/obesity (OW/OB) exhibit poor cardiometabolic
health, yet mechanisms influencing brain health remain unclear. We examined the dif-
ferences in neurological-related circulating proteins in plasma among children with
metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) and
the association with metabolic syndrome markers.
Methods: In this cross-sectional study, we included 84 Caucasian children (39% girls),
aged 10.1 ± 1.1 years, from the ActiveBrains project (NCT02295072). A ninety-
two-protein targeted approach using Olink's ® technology was used.
Results: We identified distinct concentrations of CD38, LAIR2, MANF and NRP2
proteins in MHO compared with MUO. Moreover, individual metabolic syndrome
(MS) markers were linked to nine proteins (CD38, CPM, EDA2R, IL12, JAMB, KYNU,
LAYN, MSR1 and SMOC2) in children with OW/OB. These proteins play crucial roles
in diverse biological processes (e.g., angiogenesis, cholesterol transport, nicotinamide
adenine dinucleotide (NAD+) catalysis and maintenance of blood–brain barrier)
related to brain health.
Conclusion: Our proteomics study suggests that cardiometabolic health (represented
by MHO/MUO or individual MS markers) is associated with the concentration in
plasma of several proteins involved in brain health. Larger-scale studies are needed to
contrast/confirm these findings, with CD38 standing out as a particularly noteworthy
and robust discovery.





